The long-term effects of the lipid-lowering agent fenofibrate in hyperlipidemic heart transplant recipients.
Boissonnat
P
P
INSERM U.63 Laboratory of Biochemistry, Hôpital Cardiologique, Lyon, France.
Salen
P
P
Guidollet
J
J
Ferrera
R
R
Dureau
G
G
Ninet
J
J
Renaud
S
S
de Lorgeril
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D004361:Drug Tolerance; D011345:Fenofibrate / Q000009:adverse effects / Q000627:therapeutic use*; D016027:Heart Transplantation; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008137:Longitudinal Studies; D008875:Middle Aged; D011446:Prospective Studies
D008055:Lipids; D011345:Fenofibrate